NEWS
TOPICS
Cancer Vaccines
Clinical Trials
Emerging Markets
Infectious Diseases
Influenza
Manufacturing
Partnering
R&D
Regulatory
Supply Chain
ANALYSIS
FiercePharma news, curated by the crowd
by Tracy Staton

A prosperous new year for pharma? Let's check the tea leaves
by Tracy Staton

Industry Voices

More commentary

About Us - Staff
FEATURES
Top 5 Vaccine Companies by Revenue - 2012

Top 10 DTC Pharma Advertisers - H1 2013

20 Top-selling Vaccines -- H1 2012

Top 20 orphan drugs by 2018
Top 10 pharma companies by employees

10 promising therapeutic vaccines 2012

Major FDA vaccine approvals of 2012

Top 15 Drug Launch Superstars
LIBRARY
eBooks
Webinars
Videos
Surveys
Multimedia
View All
EVENTS
Jobs
Marketplace

Tag:

seasonal flu

Latest Headlines

Latest Headlines

Novavax reports PhII success for quadrivalent seasonal flu vax

August 3, 2015 | By Amirah Al Idrus

Novavax is making waves in the influenza space, reporting positive Phase II results for its quadrivalent seasonal flu vaccine on Thursday.

THE LIBRARY: WEBINAR

Precision Medicine: Opportunities and Challenges for Clinical Trials

| Wednesday, September 2nd | 11:30am ET / 8:30am PT | Presented by: Medpace

In this webinar, Dr. Frank Smith will explore advances in precision medicine and how it is affecting clinical research. As a pediatric hematologist/oncologist, he will use his extensive clinical and research background as a backdrop for the discussion. Register Now!

MORE ITEMS

EVENTS

PMI Global Congress 2015 - North AmericaOctober 11-13, 2015 — Orlando, FL — Sponsored By: PMI
BioImmersionOctober 14-16 — Chicago, IL — Sponsored by: Biotech Primer
Drug Development ImmersionNovember 19-20 — Boston, MA — Sponsored by: BioTech Primer

MORE EVENTS

Press Releases

Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs
Ardelyx Regains NaP2b Program from Sanofi
Heat Biologics Announces Clinical Trial Combining HS-110 and PD-1 Checkpoint Inhibitor in NSCLC
Agena Bioscience Opens Office in Shanghai, China
American Journal of Kidney Disease Publication Confirms Significant Patient Advantages with HHD versus PD
More Press Releases

Sponsored Links

A publication ofFierceMarkets

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Click here to get your free weekly email briefing today!

The FierceMarkets Network:

Telecom

FierceCable
FierceDeveloper
FierceWireless:Europe
FierceWirelessTech
FierceOnlineVideo
FierceTelecom
FierceWireless
FierceInstaller

Marketing & Retail

FierceCMO
FierceMobileMarketer
FierceRetail
FierceRetailIT
FierceMobileRetail

Healthcare

FierceEMR
FierceHealthcare
FierceHealthFinance
FierceHealthIT
FierceHealthPayer
FierceHealthPayerAntiFraud
FierceMobileHealthcare
FiercePracticeManagement
Hospital Impact

Government

FierceGovernment
FierceGovernmentIT
FierceHomelandSecurity
FierceMobileGovernment
FierceCities
FierceGovHealthIT

Life Sciences

FierceBiotechResearch
FierceBiotech
FierceBiotechIT
FierceCRO
FierceDiagnostics
FierceDrugDelivery
FierceMedicalDevices
FiercePharma
FiercePharmaAsia
FiercePharmaManufacturing
FiercePharmaMarketing
FierceVaccines
FierceAnimalHealth

Enterprise IT

FierceBigData
FierceCIO
FierceContentManagement
FierceDevOps
FierceEnterpriseCommunications
FierceITSecurity
FierceMobileIT

Energy

FierceEnergy
SmartGridNews
FierceWater

Finance

FierceCFO
FierceFinanceIT